| Popis: |
Objective. This systematic review is conducted to synthesize recent empirical evidence of Zero-markup Policy for Essential Drugs Effect on Medical Treatment in China. Methods. We searched the PubMed, Embase, Scopus, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) for all related studies published from inception to 30 April 2019 without restriction on language. In addition, grey literatures were captured through other sources, such as OpenGrey and Open Access Theses and Dissertations (OATD), to avoid selection bias. Methodological quality were evaluated using the PRISMA statement the Newcastle Ottawa Scale Collaboration tool. Results. Thirty-four full texts were initially searched, but only nine studies met our inclusion criteria. Most of studies indicated the significant reduction for both the total expense and drug expense per visit. Additionally, outpatient and inpatient services indicated increasing trends in annual patient-visits. Conclusions. In conclusion, the available limited, relative low-quality evidence does not support the long-term association between zero-markup policy for essential drugs and reduced medical expenditure. Further longitudinal studies that provide data for hospitals over a wider range of regions would make the economic effects more discursive. |
